Detalhe da pesquisa
1.
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.
Immunity
; 53(4): 805-823.e15, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053330
2.
The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer.
Front Med (Lausanne)
; 5: 271, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30320116